Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasmodium Falciparum Malaria (Uncomplicated)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01407887
What this trial is testing

Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children

Who this might be right for
Uncomplicated Falciparum Malaria
Heidelberg University 180
Large-scale testing (Phase 3)Study completedNCT00386763
What this trial is testing

Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

Who this might be right for
MalariaFalciparum
Novartis 890
Not applicableStudy completedNCT02645604
What this trial is testing

Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali

Who this might be right for
Accute Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 154
Large-scale testing (Phase 3)Study completedNCT01231113
What this trial is testing

Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana

Who this might be right for
Pregnancy Complicated by Malaria as Antepartum Condition
Kwame Nkrumah University of Science and Technology 417
Post-approval studies (Phase 4)Study completedNCT05070520
What this trial is testing

Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites

Who this might be right for
MALARIA
Programme National de Lutte contre le Paludisme, Niger 259
Not applicableStudy completedNCT00460369
What this trial is testing

Treatment of Uncomplicated Malaria in Benin

Who this might be right for
Uncomplicated Malaria
Institut de Recherche pour le Developpement 240
Not applicableStudy completedNCT00164216
What this trial is testing

Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in Peru

Who this might be right for
Malaria Falciparum
Centers for Disease Control and Prevention 208
Testing effectiveness (Phase 2)Study completedNCT05689047
What this trial is testing

Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)

Who this might be right for
Acute Malaria
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 38
Post-approval studies (Phase 4)Study completedNCT01213433
What this trial is testing

Amodiaquine+Artesunate for Uncomplicated Malaria Treatment

Who this might be right for
Uncomplicated Malaria
Centre Muraz 150
Post-approval studies (Phase 4)Study completedNCT00444106
What this trial is testing

Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function

Who this might be right for
MalariaFalciparum
Novartis 265
Post-approval studies (Phase 4)Study completedNCT06300970
What this trial is testing

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

Who this might be right for
Plasmodium FalciparumMalariaUncomplicated Malaria
Centers for Disease Control and Prevention 352
Post-approval studies (Phase 4)Study completedNCT04370977
What this trial is testing

In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)

Who this might be right for
Malaria
Centro de Investigacao em Saude de Manhica 630
Post-approval studies (Phase 4)Study completedNCT03773536
What this trial is testing

Efficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in Zanzibar

Who this might be right for
Plasmodium Falciparum Malaria
Professor Anders Björkman 146
Testing effectiveness (Phase 2)Study completedNCT00331136
What this trial is testing

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Medicines for Malaria Venture 60
Post-approval studies (Phase 4)Ended earlyNCT00374205
What this trial is testing

Randomized Trial on Effectiveness of ACTs in Ghana

Who this might be right for
Malaria, Falciparum
Bernhard Nocht Institute for Tropical Medicine 245
Post-approval studies (Phase 4)Study completedNCT02052323
What this trial is testing

Harmonized AS/MQ Efficacy Study - Thailand

Who this might be right for
Malaria
Armed Forces Research Institute of Medical Sciences, Thailand 48
Testing effectiveness (Phase 2)Study completedNCT01955382
What this trial is testing

Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria

Who this might be right for
MalariaSevere Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableEnded earlyNCT00331708
What this trial is testing

Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria

Who this might be right for
Malaria
Professor Karen I Barnes 3
Not applicableStudy completedNCT00157885
What this trial is testing

A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.

Who this might be right for
Malaria, FalciparumMalaria, Vivax
Menzies School of Health Research 400
Testing effectiveness (Phase 2)Study completedNCT07811882
What this trial is testing

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 95
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation